Related references
Note: Only part of the references are listed.Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme
Chunsheng Liu et al.
CLINICAL CANCER RESEARCH (2007)
Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice
Shanthi Ganesh et al.
CANCER RESEARCH (2007)
A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells
Sebastian Tuve et al.
JOURNAL OF VIROLOGY (2006)
Hyperfractionated or accelerated radiotherapy in head and neck cancer:: a meta-analysis
Jean Bourhis et al.
LANCET (2006)
Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses
PS Reddy et al.
CLINICAL CANCER RESEARCH (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
J Bernier
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Coxsackievirus and adenovirus receptor expression on primary osteosarcoma specimens and implications for gene therapy with recombinant adenoviruses
HCA Graat et al.
CLINICAL CANCER RESEARCH (2005)
Novel agents and incremental advances in the treatment of head and neck cancer
FR Khuri et al.
SEMINARS IN ONCOLOGY (2004)
Use of replicating oncolytic adenoviruses in combination therapy for cancer
RL Chu et al.
CLINICAL CANCER RESEARCH (2004)
Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer
GH Yoo et al.
LARYNGOSCOPE (2004)
Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer Xenografts
M Zhang et al.
MOLECULAR THERAPY (2003)
Replicative oncolytic adenoviruses in multimodal cancer regimens
DE Post et al.
HUMAN GENE THERAPY (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
Share Paper
